An Indian government-backed COVID-19 vaccine could be launched as early as February as ‘last-stage’ trials begin this month.
A private company, Bharat Biotech, is developing COVAXIN alongside the government-run Indian Council of Medical Research (ICMR).
WASSCE results of Rivers State candidates not withheld – WAEC
US election: Biden wins Arizona, Democrat’s first in 24 years
Studies have so far shown that the vaccine is safe and effective, a senior government scientist told the Reuters news agency.
Bharat Biotech, a private company that is developing COVAXIN alongside the government-run Indian Council of Medical Research had earlier hoped to launch it only in the second quarter of next year.
A senior ICMR scientist Rajni Kant, who is also a member of its COVID-19 task force, on Thursday at the headquarters of the research centre in New Delhi said the vaccine has “shown good efficacy”.
If launched in February, COVAXIN would be the first India-made vaccine to be rolled out.
Join Daily Trust WhatsApp Community For Quick Access To News and Happenings Around You.
